Back to News
Market Impact: 0.35

Prediction: 2025's Second-Worst-Performing Dow Jones Stock Will Beat the Market in 2026

CRMUNHMSFTADBE
Artificial IntelligenceTechnology & InnovationCompany FundamentalsCorporate Guidance & OutlookCorporate EarningsCapital Returns (Dividends / Buybacks)Antitrust & CompetitionInvestor Sentiment & Positioning
Prediction: 2025's Second-Worst-Performing Dow Jones Stock Will Beat the Market in 2026

Salesforce has underperformed peers in 2025 (down ~31% YTD and down 14.9% since joining the Dow) amid slowing revenue growth with management guiding roughly 9% revenue growth for fiscal 2026. The firm is pushing agentic AI (Agentforce) as a growth lever but faces the risk that AI could reduce license counts and pricing power as customers do more with fewer seats; competition from integrated suites like Microsoft is also highlighted. Financially the business shows strong fundamentals: a 21.2% operating margin, management guiding non-GAAP full-year operating margin of 34.1%, forward P/E ~20.3, forward P/FCF ~17.7, roughly double the cash and equivalents versus long-term debt, a low price-to-sales valuation (near decade lows) and a 0.7% dividend yield. Investors should watch the Dec. 3 earnings call for management’s plans to translate AI deployments into top-line growth while preserving margins; the write-up frames the shares as a contrarian, lower-risk long-term opportunity if competitive erosion is contained.

Analysis

Market structure: AI is reallocating value from per-seat SaaS vendors to integrated infra+app platforms (MSFT, NVDA, cloud providers). Winners are cloud/compute and platform-integrators that can monetize by attachment (Azure+365); losers are standalone CRM/ADBE-like franchises that face seat-count deflation and pricing pressure. Expect continued multiple compression in exposed SaaS names until durable AI monetization (measured by ARPU lift, not just agent adoption) is visible over two consecutive quarters. Risk assessment: Near-term (days–weeks) the Dec. 3 CRM earnings call is a binary catalyst; an FY26 revenue guide <8% or margin guide <32% is a material downside trigger (20%+ drawdown tail). Medium-term (3–12 months) risks include Microsoft bundling and customer consolidation; long-term (12–36 months) tail risk is commoditization of CRM as AI reduces seat demand. Hidden dependency: Agentforce could both cannibalize seats and increase stickiness—net effect depends on realized ARPU per account, which management must disclose. Trade implications: Tactical: establish a small (2–3% portfolio) long in CRM ahead of Dec. 3, size to 4–6% if post-earnings weakness >10% or if guidance beats (revenue ≥9.5% and non-GAAP margin ≥34%). Hedge: pair long CRM vs short ADBE equal notional (1–2% each) to capture relative recovery. Options: buy Jan-2026 LEAPS calls for long convexity (25–35% of intended exposure) and use small (0.5–1% portfolio) Dec earnings straddle to trade the event; cut on clear guidance miss. Contrarian angles: The market may have over-discounted CRM: current multiples price in ~low-single-digit growth; modest re-acceleration (10–20% upside to revenue/ARPU) could drive 30–50% equity upside over 12 months. Historical parallel: Oracle-era consolidation where on-prem sellers re-priced then recovered after product re-architecture; likewise CRM’s strong cash balance (~2x cash vs long-term debt) limits structural downside. Conversely, if MSFT converts >10% of large-enterprise CRM spend in 24 months, downside will be severe — use size/stop discipline.